S0635: Erlotinib and Bevacizumab in Stage IIIB and IV Bronchioloalveolar Carcinoma
Clinical trial NCT00436332 · COMPLETED
Trial details
- NCT number
- NCT00436332
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2019-07-20
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.